Efficacy of naftopidil in patients with overactive bladder associated with benign prostatic hyperplasia prospective randomized controlled study to compare differences in efficacy between morning and evening medication

Efficacy of naftopidil in patients with overactive bladder associated with benign prostatic hyperplasia : prospective randomized controlled study to compare differences in efficacy between morning and evening medication

A total of 100 patients with benign prostatic hyperplasia (BPH) and overactive bladder (OAB) symptoms (BPH/OAB), enrolled between June 2006 to March 2008, were randomly divided into 2 groups of morning medication (M) and evening medication (E) groups, then 50 mg of naftopidil was given once a day af...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 57(2011), 1 vom: 08. Jan., Seite 7-13
1. Verfasser: Sakai, Hideki (VerfasserIn)
Weitere Verfasser: Igawa, Tsukasa, Onita, Toru, Furukawa, Masataka, Hakariya, Tomoaki, Hayashi, Mikio, Matsuya, Fukuzo, Shida, Yohei, Nishimura, Naoki, Yogi, Yasuo, Tsurusaki, Toshifumi, Takehara, Kousuke, Nomata, Koichiro, Shiraishi, Kazutaka, Shono, Takefumi, Aoki, Daiyu, Kanetake, Hiroshi
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 2011
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Comparative Study English Abstract Journal Article Randomized Controlled Trial Adrenergic alpha-Antagonists Naphthalenes Piperazines naftopidil R9PHW59SFN